BC-1382
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 565383

CAS#: 1013753-99-5

Description: BC-1382 is a potent ubiquitin E3 ligase HECTD2 inhibitor which specifically disrupts the HECTD2/PIAS1 interaction.


Chemical Structure

img
BC-1382
CAS# 1013753-99-5

Theoretical Analysis

MedKoo Cat#: 565383
Name: BC-1382
CAS#: 1013753-99-5
Chemical Formula: C23H29N3O5S
Exact Mass: 459.18
Molecular Weight: 459.560
Elemental Analysis: C, 60.11; H, 6.36; N, 9.14; O, 17.41; S, 6.98

Price and Availability

Size Price Availability Quantity
250mg USD 950 2 Weeks
Bulk inquiry

Synonym: BC1382; BC 1382; BC-1382

IUPAC/Chemical Name: (S)-N-(1-((2-Methoxybenzyl)amino)-1-oxopropan-2-yl)-1-(phenylsulfonyl)piperidine-4-carboxamide

InChi Key: RCWXKFCEGKXUIN-KRWDZBQOSA-N

InChi Code: InChI=1S/C23H29N3O5S/c1-17(22(27)24-16-19-8-6-7-11-21(19)31-2)25-23(28)18-12-14-26(15-13-18)32(29,30)20-9-4-3-5-10-20/h3-11,17-18H,12-16H2,1-2H3,(H,24,27)(H,25,28)/t17-/m0/s1

SMILES Code: O=C(C1CCN(S(=O)(C2=CC=CC=C2)=O)CC1)N[C@@H](C)C(NCC3=CC=CC=C3OC)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Product Data:
Biological target: BC-1382 is an ubiquitin E3 ligase HECTD2 inhibitor.
In vitro activity: BC-1382 was tested in an in vitro binding assay (Fig. 7C). The result suggested that BC-1382 is a potent inhibitor of HECTD2 with IC50 (median inhibitory concentration) ≈ 5 nM toward disrupting the HECTD2/PIAS1 interaction. BC-1382 drastically increased PIAS1 protein level in a nonstimulus condition with IC50 ≈100 nM (fig. S8B). PIAS3, PIAS4, and HECTD2 protein levels appeared to be unchanged. BC-1382 did not alter mRNA levels of PIAS1, PIAS4, or HECTD2 (fig. S8C). BC-1382 also improved PIAS1 protein stability by increasing its t1/2 (fig. S8D). BC-1382 suppressed LPS-induced PIAS1 degradation and restored PIAS1 protein levels at 800 nM (fig. S8E). Last, BC-1382 was able to suppress LPS-induced proinflammatory cytokines released by human peripheral blood mononuclear cells (PBMCs) (fig. S8F). Reference: Sci Transl Med. 2015 Jul 8;7(295):295ra109. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706383/
In vivo activity: To assess the in vivo anti-inflammatory activity of BC-1382, it was tested using P. aeruginosa– and LPS-induced pneumonia models. Briefly, C57BL/6J mice were challenged intratracheally with PA103 (104 CFU per mouse) or LPS (3 mg/kg). BC-1382 was given through intraperitoneal injection (10 mg/kg) at the same time. BC-1382 did not appear to affect BAL bacteria (Fig. 7D). However, it significantly decreased lavage protein concentrations, lavage cell counts, and cell infiltrates in both PA103-stimulated (Fig. 7, E, F, and H) and LPS-stimulated (fig. S9, A, B, and D) mice. Further, BC-1382 significantly decreased lavage cytokine levels in both models (Fig. 7G and fig. S9C). Reference: Sci Transl Med. 2015 Jul 8;7(295):295ra109. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706383/

Preparing Stock Solutions

The following data is based on the product molecular weight 459.56 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: 1. Coon TA, McKelvey AC, Lear T, Rajbhandari S, Dunn SR, Connelly W, Zhao JY, Han S, Liu Y, Weathington NM, McVerry BJ, Zhang Y, Chen BB. The proinflammatory role of HECTD2 in innate immunity and experimental lung injury. Sci Transl Med. 2015 Jul 8;7(295):295ra109. doi: 10.1126/scitranslmed.aab3881. PMID: 26157031; PMCID: PMC4706383.
In vitro protocol: 1. Coon TA, McKelvey AC, Lear T, Rajbhandari S, Dunn SR, Connelly W, Zhao JY, Han S, Liu Y, Weathington NM, McVerry BJ, Zhang Y, Chen BB. The proinflammatory role of HECTD2 in innate immunity and experimental lung injury. Sci Transl Med. 2015 Jul 8;7(295):295ra109. doi: 10.1126/scitranslmed.aab3881. PMID: 26157031; PMCID: PMC4706383.
In vivo protocol: 1. Coon TA, McKelvey AC, Lear T, Rajbhandari S, Dunn SR, Connelly W, Zhao JY, Han S, Liu Y, Weathington NM, McVerry BJ, Zhang Y, Chen BB. The proinflammatory role of HECTD2 in innate immunity and experimental lung injury. Sci Transl Med. 2015 Jul 8;7(295):295ra109. doi: 10.1126/scitranslmed.aab3881. PMID: 26157031; PMCID: PMC4706383.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Coon TA, McKelvey AC, Lear T, Rajbhandari S, Dunn SR, Connelly W, Zhao JY, Han S, Liu Y, Weathington NM, McVerry BJ, Zhang Y, Chen BB. The proinflammatory role of HECTD2 in innate immunity and experimental lung injury. Sci Transl Med. 2015 Jul 8;7(295):295ra109. doi: 10.1126/scitranslmed.aab3881. PubMed PMID: 26157031; PubMed Central PMCID: PMC4706383.